Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Regulatory News (PHRM)

  • There is currently no data for PHRM

Management Appointments

17 Dec 2008 17:52

RNS Number : 3515K
Phorm Inc
17 December 2008
 



Phorm, Inc. ("Phorm" or the "Company")

Management Appointments

Phorm (AIM: PHRM and PHRX), the innovative digital advertising business, today announces three key executive appointments. These changes will strengthen the Company's leadership team through the next important phase of its development. The UK based executive management will ensure the deliverability of the Group's core strategic objective of deploying Phorm's technology both in the UK and internationally whilst managing cash resources in a prudent fashion.

Nan Richards is appointed Deputy Chief Executive Officer based in London. Nan's primary responsibility will be to work with Chief Executive, Kent Ertugrul, to deliver Phorm's operational goals. Nan Richards was previously President of Turner Broadcasting System Europe, a division of Time Warner. She brings with her a wealth of operational and strategic experience having spent 20 years working on Turner's leading broadcast brands including CNN, Cartoon Network and TCM. 

Hugo Drayton, UK Chief Executive, will leave the Company by mutual agreement at the end of 2008, though he will remain an advisor to the Company. Hugo Drayton commented: "My time with Phorm has been exciting and rewarding. Whilst I am looking forward to exploring new challenges in the fast-evolving media world, I am delighted that I will continue to contribute to the dynamic, industry-changing future of Phorm. I am very happy with the progress we've made in recent months with our ISP partners and our advertising and publishing clients. In 2009 we expect that Phorm's Open Internet Exchange (OIX) will be commercially deployed and I am very proud that the team we have established is now fully prepared to deliver on the Company's enormous potential."

Andrew Croxson is appointed Global CFO on an interim basis. Andrew joins from the Technology, Media and Telecommunications (TMT) specialists Ingenious Consulting. Prior to that, Andrew was a partner at Spectrum Strategy Consultants. He is an ACA qualified chartered accountant and has a Masters Degree from both Oxford and Cambridge Universities. As well as Andrew's significant financial knowledge, he also brings deep experience of advising brand leading media and technology companies and strategic insights into building and scaling global operations. He will replace Lynne Millar who has resigned as UK CFO.

Nick Barnett, currently Phorm's UK Commercial Director, is promoted to the newly created role of UK Managing Director based in London. Nick will be responsible for the UK business working with ISPs on the trial and deployment of Phorm's technology as well as overseeing our commercial relationships with advertisers, publishers and ad networks. Before joining Phorm, Nick was VP of Corporate Strategy and Development at Telefonica O2 Europe and prior to that he was a senior manager with McKinsey & Company specialising in the TMT sector.

Kent Ertugrul, Chief Executive of Phorm, commented: "I'd like to welcome Nan, Andrew, and Nick to their new roles. Their appointments are central to the delivery of our strategic objectives through the next important phase of our development.

 

"I thank both Hugo and Lynne for their significant contributions and wish them well in their future endeavours. They have helped lay the foundations for a successful commercial launch in the UK and beyond. I am delighted that Hugo will build on his previous achievements with Phorm as an advisor.

"We have made significant progress in the development of partnerships and the testing of our technology. I am also pleased that we have completed the trial with BT and look forward to moving to the next stage of development.

"I am confident that we have the right talent at both the Board and executive level to deliver on the huge potential of our technology and the business opportunity that lies ahead. I believe that we are now uniquely placed to lead the introduction of privacy-assured behavioural advertising across the whole of the Internet."

For Phorm Enquiries:

Kent Ertugrul (Chief Executive)

+44 20 7638 9571

Citigate Dewe Rogerson

+44 20 7638 9571

Simon Rigby

Justin Griffiths

Canaccord Adams Limited

+44 20 7050 6500

(Nominated Adviser)

Mark Williams

Andrew Chubb

About Phorm:

Phorm is an innovative technology company specialising in delivering behaviourally and contextually targeted advertising while preserving users' personal privacy and security. Phorm's partners include leading Internet Service Providers (ISPs), Publishers, Ad Networks and Advertisers.

Phorm is a Delaware, US incorporated company, with offices in New York and London. The Company was admitted to the AIM market of the London Stock Exchange in 2004 and has over 100 employees.

For more information, please visit: www.phorm.com http://www.phorm.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAFKOKQOBDDOBD
Date   Source Headline
5th Jan 20107:00 amRNSTransfer of shares
17th Dec 200911:51 amRNSPurchase of Shares and Total Voting Rights
4th Nov 20092:18 pmRNSNotification of major interest in shares
2nd Nov 200912:42 pmRNSResult of AGM
6th Oct 20092:07 pmRNSNotice of AGM
2nd Oct 20097:00 amRNSNotification of major interest in shares
21st Sep 20097:00 amRNSInterim results
14th Sep 20098:57 amRNSNotification of Results
5th Aug 20097:00 amRNSTransfer of Shares
8th Jul 20098:27 amRNSOperational Update
6th Jul 20099:22 amRNSStatement on UK operations
30th Jun 20097:13 amRNSAnnual Accounts
19th Jun 200911:06 amRNSTotal Voting Rights
18th Jun 20097:00 amRNSFinal Results
10th Jun 20097:00 amRNSPlacing to raise ?15 million
3rd Jun 200911:00 amRNSPhorm announces Webwise Discover
21st May 20097:00 amRNSKorean Market Trial
27th Apr 200910:31 amRNSStatement re Apology from "New Media Age" Magazine
14th Apr 20096:23 pmRNSPhorm Statement re EU Commission
9th Apr 20093:57 pmRNSAIM Block Admission
30th Mar 20097:00 amRNSKorean Market Trial
26th Mar 20097:03 amRNSGrant of Options
19th Mar 20091:31 pmRNSGrant of Options
18th Mar 20097:00 amRNSChange of Broker
13th Mar 20095:03 pmRNSShare Issue - Replacement
13th Mar 20092:46 pmRNSShare Issue
11th Mar 20099:49 amRNSAnnouncement of Appointments
4th Mar 20093:18 pmRNSCity Events Wire
17th Dec 20085:52 pmRNSManagement Appointments
15th Dec 20087:00 amRNSBT Trial Update
1st Dec 20087:00 amRNSPhorm Announces Board Changes
5th Nov 20087:46 amRNSDisclosure of Share Sale
22nd Oct 20085:14 pmRNSGrant of options
14th Oct 200810:15 amRNSCancellation of admission of shares
30th Sep 20087:00 amRNSInterim Results
29th Sep 20087:00 amRNSCommencement of BT Trial
22nd Sep 200811:15 amRNSResponse to Statement by BERR
4th Sep 20087:00 amRNSPhorm Update
18th Aug 20087:00 amRNSAppointment of Independent Bo
24th Jun 20087:00 amRNSTransfer of Shares
14th May 20084:45 pmRNSExercise of Options
14th May 200812:55 pmRNSAnnual Report and Accounts
10th Apr 20087:01 amRNSFinal Results
4th Apr 20084:23 pmRNSNotification of Holding
4th Apr 20084:16 pmRNSNotification Of Shareholding
4th Apr 200812:11 pmRNSNotification Of Shareholding
19th Mar 20087:01 amRNSIssue of Equity
13th Mar 200811:32 amRNSResult of Stockholder Meeting
11th Mar 20087:02 amRNSRe Share Price Movement
28th Feb 20085:50 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.